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Background: Relatively few programmes have attempted to actively engage the private sector in national malaria
control efforts. This paper evaluates the health impact of a large-scale distribution of insecticide-treated nets (ITNs)
conducted in partnership with a Zambian agribusiness, and its cost-effectiveness from the perspective of the
National Malaria Control Programme (NMCP).
Methods: The study was designed as a cluster-randomized controlled trial. A list of 81,597 cotton farmers was
obtained from Dunavant, a contract farming company in Zambia’s cotton sector, in December 2010. 39,963 (49%)
were randomly selected to obtain one ITN each. Follow-up interviews were conducted with 438 farmers in the
treatment and 458 farmers in the control group in June and July 2011. Treatment and control households were
compared with respect to bed net ownership, bed net usage, self-reported fever, and self-reported confirmed
malaria. Cost data was collected throughout the programme.
Results: The distribution effectively reached target beneficiaries, with approximately 95% of households in the
treatment group reporting that they had received an ITN through the programme. The average increase in the
fraction of household members sleeping under an ITN the night prior to the interview was 14.6 percentage points
(p-value <0.001). Treatment was associated with a 42 percent reduction in the odds of self-reported fever (p-value
<0.001) and with a 49 percent reduction in the odds of self-reported malaria (p-value 0.002). This was accomplished
at a cost of approximately five US$ per ITN to Zambia’s NMCP.
Conclusions: The results illustrate that existing private sector networks can efficiently control malaria in remote
rural regions. The intra-household allocation of ITNs distributed through this channel was comparable to that of
ITNs received from other sources, and the health impact remained substantial.
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Despite massive international efforts, malaria continues
to be one of the principal causes of ill health as well as
mortality in sub-Saharan Africa today with approxi-
mately one million deaths per year globally [1,2]. On
average, individuals living in highly endemic areas are
estimated to suffer at least one bout of malaria per year,
resulting in an estimated total number of 225 million
malaria cases causing an average of five work days lost* Correspondence: richard.sedlmayr@gmail.com
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reproduction in any medium, provided the or[3] and an average direct cost of three to seven US$ for
treatment alone [4].
Insecticide-treated bed nets (ITNs) are considered
one of the most effective interventions against malaria
[5,6] and have been endorsed by the World Health
Organization for the global anti-malaria efforts. Com-
prehensive coverage with ITNs has been shown to lead
to a 50 percent reduction in the incidence of uncompli-
cated Plasmodium falciparum malaria episodes in areas
with stable malaria, and a reduction of 62 percent in
areas with unstable malaria [7].
Over the past decade, many countries in Africa have
bolstered efforts to make ITNs widely available throughal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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interventions [8,9]. These efforts were ushered in
through commitments by national political leadership as
well as a variety of partners such as the Global Fund and
the President’s Malaria Initiative. Among malaria control
programmes in Africa, the Zambian National Malaria
Control Programme (NMCP) has made notable progress
in scaling ITN coverage through rolling mass distribu-
tions and targeted distributions to pregnant women and
children under age five through antenatal clinics as part
of routine care [10]. These efforts have resulted in some
of the highest levels of ITN coverage and utilization on
the continent [9].
Sustaining high levels of ITN coverage is challenging.
Zambia has been particularly successful at increasing the
overall levels of coverage through consistent commit-
ments of partners even without much involvement in
the private sector for ITN distribution. Traditionally, the
private sector in Zambia, and in particular the mining
sector, has focused on provision of indoor residual
spraying (IRS) services, chemoprophylaxis and treatment
services for their employees as part of their strategy to
improve the livelihoods of their labour force, and based
on the recognition that it may pay to reduce malaria
where they operate [11,12]. The challenge in sustaining
coverage not only relates to procurement costs, but also
to the costs of distributing bulky ITNs to the household
level in remote rural areas. As coverage increases, the
challenge of tracking those households who have been
missed by previous distribution efforts as well as those
households needing ITN replacement increases [13]. En-
gaging additional partners, especially the private sector,
in the effort to provide ITNs to those affected by malaria
is therefore a priority of Zambia’s NMCP.
In an effort to improve the well-being and productivity
of its contract farmers, Dunavant Cotton, an international
cotton agribusiness, volunteered to distribute close to
40,000 long-lasting ITNs to randomly selected farmers
during the farming season 2010/2011. The ITNs were pro-
vided by the Malaria Control and Evaluation Partnership
in Africa (MACEPA) project with funding from the Bill
and Melinda Gates Foundation through the NMCP. A
follow-up survey with participating households was
conducted in June and July 2011, which allowed an assess-
ment both of the quality of the distribution and the health
impact of the programme.
Methods
Study context
Dunavant Cotton Zambia’s core business is the purchase
and processing of locally grown cotton, and the market-
ing of cotton lint. Dunavant is the largest cotton buyer
in the country, competing with half a dozen other com-
panies for crop. It signs agreements with smallholdercontract farmers at the beginning of the growing season,
allowing farmers to obtain farming inputs such as seed
and fertilizer on a loan basis in exchange for a commit-
ment to the year’s cotton output exclusively to the
Dunavant. The total loan amount is deducted from the
delivery at the end of the harvesting season. To guaran-
tee a smooth distribution of resources and a rapid turn-
around on cotton purchases, Dunavant maintains a
highly decentralized distribution system. In the 2010–11
season, 62 regional warehouses (“sheds”) supervised
1,507 local sales representatives (“distributors”), who co-
ordinate all interactions with locally partnering farmers.
Study population
Dunavant is active in four of Zambia’s ten provinces:
Eastern, Southern, Central and Lusaka. As of 2010, the
total population in these provinces is approximately 6.8
million individuals, living in over one million households
[14]. As of December 2010, 81,597 cotton farming
households in these provinces had standing contractual
agreements with Dunavant. Cotton is the primary cash
crop for many small-scale farmers in the area. Most
typically, small scale farms use one or two hectares for
maize (as their primary source of nutrition) and about
one hectare for cotton as their primary cash crop [15].
Study design
The study used a cluster-randomized design as illus-
trated in Figure 1. The study population was composed
of all 81,597 farmers who had a standing collaborative
agreement with Dunavant Cotton for the 2010/11
season as of December 23th, 2010. The administrative
database provided to the study by Dunavant contained
commercial information on loans and farming inputs,
but little information on households’ socioeconomic
background.
Randomization
ITNs were distributed following a stratified cluster-
randomized design. A complete listing of farmers was
extracted from Dunavant’s database on December 23th,
2010. In order to ensure a balanced rollout across
regions, each of the 62 regional distribution offices
(“sheds”) was treated as separate stratum in the
randomization. Within each stratum, 49% of clusters
were assigned to the ITN programme through a random
number draw generated by Stata© 11 statistical software
package. In most cases, clusters corresponded to all
farmers in a given village working with Dunavant,
though some of the larger villages had multiple distribu-
tors, which were then considered as separate clusters.
Based on the available number of ITNs, 39,963 farmers
were assigned to the treatment group, while 41,634
farmers were assigned to the control group.
 Figure 1 Study design.
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Following the randomization, ITNs were distributed be-
tween January 20th and January 28th 2011. As a fair and
simple distribution rule, it was determined that each
household would receive exactly one ITN through the
programme. ITNs were provided for free and without
conditions, and could explicitly be kept even by farmers
who would choose to discontinue the contractual relation-
ship with Dunavant. In order to evaluate the impact of the
distribution at the household level, and to verify the accur-
acy of the ITN distribution, a household survey was
conducted between June 20th and July 11th in a randomly
selected subset of 144 clusters. The household survey
sampling followed a 3-step procedure. In a first step, 36
regional offices were randomly selected from the 62 offices
operated by Dunavant. In a second step, two treatment
and two control clusters were randomly selected, resulting
in a total of 144 clusters as illustrated in Figure 2. In a last
step, 10 farmers were randomly selected in each cluster.
Within each cluster, surveyors were asked to find as many
farmers as possible, with a minimum expected tracking
rate of 70%. Across the 144 selected clusters, 1,004 of the
1,440 eligible respondent’s dwellings were identified. In
108 cases, informed consent could not be obtained, usu-
ally because of the absence of adults at the time of the sur-
vey. As a consequence, the final number of surveys
collected was 896, with 438 respondents from the treat-
ment group and 458 from the control group. All survey
data was collected on paper and double-entered using the
CSPro 4 software package.Outcome measures
ITN ownership and coverage
Household respondents were asked to list all individuals
living on their plot, and then indicate for each of these
whether or not they had been sleeping under an ITN the
night before the interview. Bed net ownership was then
verified by survey staff, who recorded the number of
ITNs hanging in the dwellings.
Morbidity outcomes
In order to assess the health impact of the ITN distribu-
tion, household respondents were asked to indicate for
each household member whether they had been sick with
fever over the two-week period preceding the interview.
Given Zambia’s sustained efforts to enforce comprehen-
sive testing of all fever cases reporting at public health
facilities, additional questions regarding the treatment of
fevers were asked. For each fever case reported, respon-
dents were asked whether a malaria blood test was
performed; if the answer was affirmative, respondents
were asked about the diagnostic result. To distinguish
fever from presumed malaria cases, two separate indicator
variables were analysed: a fever indicator, which was coded
to one whenever a household member was reported to
have suffered from a fever during the two weeks preceding
the interview, and a presumed malaria indicator, which
was coded to one if the responded reported that the fever
case had been diagnosed as malaria.
Malaria incidence in Zambia fluctuates considerably
over the course of a year (peaking in rainy season and
Figure 2 Spatial distribution of survey clusters.
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presented here are derived from the two weeks prior to
the interview. The survey period (June and July) corre-
sponds to the end of the malaria transmission season,
when the burden of malaria is very close to (if slightly
below) the annual average. According to Zambia’s 2011
Health Management Information System, the months of
June and July accounted for 8.2% and 5.9% of yearly
malaria cases [16].
Statistical analysis
Basic descriptive statistics were computed for bed net
ownership and coverage in both the treatment and con-
trol groups. In order to quantify the relative risk reduc-
tion achieved by additional ITN distribution, standard
logistic regression models were estimated using self-
reported fever and reported confirmed malaria as
dependent variables. To investigate whether the add-




Children under 5 0.98 0.98
Children 5-14 2.04 1.72
Ages 15 and older 3.47 1.86
Maize area (hectares), 2010-11 1.87 1.95
Cotton area (hectares), 2010-11 1.23 1.12
a) Mean differences are adjusted for 144 clusters in the survey data.the most vulnerable population group, separate models
for the children under the age of five were estimated. To
adjust for the spatial correlation of regression residuals,
standard errors were clustered at the distributor level.
All analysis was conducted using the Stata© 11 statistical
software package.
Results
Baseline characteristics and balance test
Table 1 provides descriptive statistics at the household
level by study arm. Average household size was 6.3, with
nearly half of the household members being under the
age of 15. Farms were rather small on average, using ap-
proximately two hectares to grow maize and one hectare
to grow cotton on average, with much smaller amounts
of lands used for other crops such as groundnuts, sun
flowers and sweet potatoes. As Table 1 shows, no differ-
ences were detected between treatment and controls
with respect to household composition or farm size.Intervention (Treatment) Differencesa)
N=438
Mean Std.dev. Mean p-value
0.99 1.00 0.01 0.894
1.98 1.73 −0.05 0.695
3.29 1.79 −0.17 0.312
1.79 2.09 −0.08 0.674
1.15 0.86 −0.08 0.445
Table 2 “Did this household receive a mosquito net from
Dunavant this season?”
Control Intervention (Treatment)
Yes 3 (0.7%) 413 (94.3%)
No 452 (98.7%) 20 (4.6%)
No response / don’t know 3 (0.7%) 5 (1.1%)
Total 458 (100%) 438 (100%)
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As shown in Table 2, targeting appears to have been
fairly accurate, with less than 5% of ITNs reported miss-
ing in the treatment group.
Impact on ITN utilization
Figure 3 shows average utilization rates in the treatment
and control groups. In the control group, utilization of the
available ITNs was approximately 40% for children under
the age of five, and at comparable levels for adults 25 and
older. The least protected group were children and teen-
agers between the ages of 5 and 19; on average, just over
10% of children of this age group were found sleeping
under an ITN the night preceding the interview. These
intra-household utilization patterns follow the NMCP’s
emphasis on prioritizing protection for newborns and
pregnant women. The impact of the net distribution is
fairly consistent across all age groups: on average, age-
specific utilization rates appear close to parallel, with a
mean increase in the likelihood of ITN utilization of ap-
proximately 15 percentage points. Relative improvements
are highest among teenagers between the ages of 15 and
19; net usage nearly doubled in this group, though in
absolute terms, the age group remains the least protected.Figure 3 Self-reported net usage by treatment arm comparison to 20Impact on morbidity
Table 3 provides an overview of self-reported morbidity
outcomes. A total of 1,131 fever cases were reported, 528
of which were coded as presumed malaria. In the control
group, the prevalence of self-reported fever was close to
24%, and the prevalence of presumed malaria was close to
12%. Figure 4 compares these data to the fever prevalence
reported in Zambia’s 2010 Malaria Indicator Survey (MIS),
which had been conducted one year earlier (in the months
between April and May).
Table 4 shows multivariate results for the health
impact of the additional ITN distributed through the
programme. In columns 1–3 of Table 4, the dependent
variable was self-reported fever during the two weeks
preceding the interview. In columns 4–6, the dependent
variable was presumed malaria. Columns 2 and 5 show
the results for children under the age of five.
On average, individuals in the treatment group faced
42% lower odds of suffering a fever, and 49% lower odds
of reporting a confirmed case of malaria. The marginal
impact appears to be slightly smaller for children under
the age of five, which can likely be attributed to the
higher average ITN coverage at baseline.
Programme cost
ITNs (Brand: BASF Interceptor) were acquired at a
wholesale price of $4.31. In addition, the NMCP paid
$0.30 in direct costs to support the core distribution
process. This number is substantially lower than bench-
mark distributions in sub-Saharan Africa [17,18] in part
because core activities (such as the identification and
sensitization of the target population as well as the stor-
age, local distribution, and tracking of ITNs) were car-
ried by Dunavant. Because of the organization’s existing10 Malaria Indicator Survey (MIS).
Table 3 Morbidity outcomes
Observations Fever cases Presumed malaria cases
Control 2,968 707 (23.82%) 350 (11.79%)
Treated 2,744 424 (15.45%) 178 (6.49%)
Total 5,712 1,131 (19.80%) 528 (9.24%)
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bution of farming inputs to the target population, these
costs were relatively small, and, from a company per-
spective thought to be offset by the goodwill generated
among partnering farmers. Compensation amounted to
12 US$ per treatment distributor, and 19 US$ for the
shed managers who oversaw ITN distribution to the dis-
tributor level. Distributor payments were contingent on
achieving at least 95% distribution accuracy according to
Dunavant’s internal tracking systems. Table 5 provides a
detailed breakdown of costs incurred by the NMCP.
General and administrative costs cover administrative
expenses associated with contracting issues. Factoring in
a leakage rate of 4.6%, the total cost per successfully
targeted ITN added up to $5.10. Some additional distri-
bution costs were incurred because of unforeseen delays
in the delivery of ITNs to Zambia: once the ITNs
arrived, the NMCP opted to use its existing logistical
infrastructure to distribute them to the shed level, rather
than leaving the task to Dunavant as originally agreed.
However, this was only done to adhere to the study
schedule, which is why the associated economic costs of
0.49 US$ per ITN should be considered nonrecurring
and, therefore, excluded. Also excluded are costs associ-
ated with study origination, design and analysis.Figure 4 Self-reported fever incidence by treatment arm, comparisonDiscussion
The results presented in this paper are notable for a num-
ber of reasons. First, they show that engaging the private
sector in distribution efforts can successfully improve ITN
coverage in areas traditionally targeted by public cam-
paigns. Second, the results show that there is both a need
of, and an appreciation for, further ITNs, as highlighted by
utilization improving across all ages in the intervention
group relative to the control group. Third, and most im-
portantly, the results suggest that additional ITNs had a
significant impact on the self-reported fever and malaria.
The estimated magnitude of the health effects appear
large, though they are within the range of the estimates
observed in controlled trial settings [7] as well as under
other programmatic settings [19,20]. Further, the benefi-
cial health effect was observed across age groups and par-
ticularly large among teenagers and adults, corresponding
to the increase in utilization that was observed by the add-
itional ITNs.
Overall, the distribution campaign analysed appears
highly cost-effective under current WHO guidelines [21].
The data collected in this paper suggests an average of ap-
proximately 0.75 cases per household and two-week
period in the absence of additional ITNs. Taking this rate
as an annual average, this implies a total malaria burden
of about three cases per person and year, or about 20 cases
per household and year. The impact estimates presented
in this paper suggest a reduction of 45% in the burden of
malaria, which translates to a reduction of nine cases of
malaria per household and year. The Roll Back Malaria
Partnership currently assumes that 80% of distributed
ITNs remain in use in the second year, and 50% in the
third [22]. This implies that each ITN averts 24 malariato 2010 Malaria Indicator Survey (MIS).
Table 4 Programme impact on morbidity
Dependent Fever last two weeks Presumed malaria
(1) (2) (3) (4) (5) (6)
OR OR OR OR OR OR
Sample All ages Ages 0-4 Age 5+ All ages Ages 0-4 Age 5+
N 5,712 881 4,831 5,712 881 4,831
Treated 0.580*** 0.618** 0.570*** 0.511*** 0.653* 0.469***
(95% CI) (0.427 - 0.788) (0.413 - 0.926) (0.413 - 0.787) (0.335 - 0.782) (0.401 - 1.064) (0.297 - 0.741)
OR=Odds ratio . 95% CI are adjusted for clustered survey sampling. Estimates in columns 1,3,4 and 6 include 5-year-age-group dummies to control for age specific
health risks.
*** p<0.01, ** p<0.05, * p<0.1.
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mated cost of $5.10 per ITN (and ignoring the time value
of money), this translates into a $0.21 cost per malaria
case averted. Assuming a case fatality rate of 3.8 per 1,000
as suggested in the 2008 WHO country profile [23], this
translates into a cost of approximately $55 to the NMCP
per malaria death averted. Under a more conservative case
fatality rate of one per 1,000 as suggested by health facility
records in the Zambian Health Management Information
System database, the estimated cost per death averted
would be US$ 210. Under both scenarios, continued dis-
tribution of ITNs in this manner should be considered
highly cost-effective, following current guidelines [24].
This may be attributed to the high baseline incidence of
malaria, high ITN usage rates, as well as low distribution
cost. To provide a benchmark, the WHO estimates the
cost per death averted to be US$ 212 on the optimistic as-
sumptions that ITNs can be exclusively targeted to the
age group with highest mortality rates (children under 5)
and have a 3 year lifespan [25].
This study has several limitations. The first and likely
most important limitation of the study lies in its reliance
on self-reported morbidity outcomes. Recent studies in
Uganda [26] as well as Zambia (Eisele at al, 2012, personal
communication) suggest that there are challenges withTable 5 Distribution costs to the NMCP
Item Campaign costs per ITN
ITNs $172,240.53 $4.31
Supplies $325.84 $0.01
Shed manager rewards $1,158.35 $0.03
Distributor rewards $5,959.09 $0.15
Logistics management $4,464.00 $0.11
General and administrative $10,400.00 $0.26
Total $194,547.82 $4.87
Total, adjusted for leakage $203,928.53 $5.10
Note: In accordance with WHO cost effectiveness standards [21], page 44
numbers are presented in international dollars, meaning that tradables (ITNs,
supplies, logistics management) are converted into US$ using market
exchange rates, while non-tradables (rewards) are converted using purchasing
power parity-adjusted exchange rates.accurate recall of malaria diagnoses at household level. It
is possible that survey respondents may have over-
reported incidences of fever and malaria; meanwhile,
given that only a fraction of fever cases got tested for
malaria, the morbidity variable may underestimate the
true disease burden. For analytical purposes, the main
interest of the study lies in the relative risk reduction,
which is not directly affected by these biases as long as
these are not affected by the treatment itself.
From a cost-effectiveness perspective, a second limita-
tion of the study is the lack of reliable mortality data.
While case fatality rates from other studies can be ap-
plied to the collected data, actual rates may differ and
display substantial regional variations due to differential
access to proper diagnosis and treatment.
Lastly, the study design is applicable only to restricted
settings because the capacity of Dunavant as a distribu-
tion channel is limited: as of 2012, the company works
with approximately 140,000 contract farming house-
holds. While the entire Zambian cotton industry may
work with as many as 300,000 households (close to two
million individuals), this still accounts for less than 20%
of Zambia’s population. Only a fraction (which varies
substantially across villages) of households in each loca-
tion is actively engaged in contract farming networks,
and it is not clear if these could effectively reach indi-
viduals that they do not have pre-existing contractual
commitments with. Further research could address this
issue.
Conclusions
The challenge of sustaining coverage levels represents an
ongoing struggle for malaria control programmes in Africa.
This study illustrates that private sector companies can be
cost-effectively integrated into large-scale ITN distribution
campaigns.
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